Dr. Stéphanie Gaillard and Dr. Bill Tew share updates to the evidence-based guideline on neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. They highlight recommendations across ...

The addition of olaparib to neoadjuvant chemotherapy improved overall survival in BRCA -mutated breast cancer, despite no improvement in pathologic response. Adding the PARP inhibitor led to a 3 ...

Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not? The following represents disclosure information provided by authors of this manuscript. All ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival compared with neoadjuvant chemo and interval cytoreductive surgery.

Select patients with breast cancer who experience pathologic complete response to neoadjuvant systemic therapy and undergo radiotherapy may be able to forego breast surgery, according to study ...

The phase 2 clinical trial (NCT03107182) included 73 eligible patients with advanced HPV + OPC. Researchers evaluated how well neoadjuvant nivolumab plus chemotherapy shrunk tumors. By comparing ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

Neoadjuvant chemotherapy is chemotherapy that's given before your primary treatment. Learn when it's used, course of treatment, benefits, and effectiveness.

“Neoadjuvant chemotherapy with [modified] FOLFIRINOX followed by chemoradiotherapy ... should be considered as one of the best options of care” for patients with locally advanced rectal cancer ...

ASCO has updated its guidelines on neoadjuvant chemotherapy use in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Exclusion criteria included patients with rectal cancer that required neoadjuvant chemotherapy or radiotherapy, stage 2 disease and lacking information regarding diagnosis, staging or treatment.